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Abstract
Collagenous gastritis (CG) is characterized by patchy 
subepithelial collagen bands. Effective treatment and 
the clinical and histological outcome of CG in children 
are poorly defined. The aim of this study is to sum-
marize the published literature on the clinical outcome 
and response to therapy of pediatric CG including two 
new cases. We performed a search in Pubmed, OVID 
for related terms; articles including management and 
clinical and/or endo-histologic follow up information 
were included and abstracted. Reported findings were 
pooled in a dedicated database including the cor-
responding data extracted from chart review in our 
patients with CG. Twenty-four patients were included 
(17 females) with a mean age of 11.7 years. The clini-
cal presentation included iron deficiency anemia and 
dyspepsia. The reported duration of follow up (in 18 
patients) ranged between 0.2-14 years. Despite most 
subjects presenting with anemia including one re-
quiring blood transfusion, oral iron therapy was only 
documented in 12 patients. Other treatment modali-
ties were antisecretory measures in 13 patients; pro-
ton pump inhibitors (12), or histamine-2 blockers (3), 
sucralfate (5), prednisolone (6), oral budesonide in 
3 patients where one received it in fish oil and triple 
therapy (3). Three (13%) patients showed no clinical 
improvement despite therapy; conversely 19 out of 22 
were reported with improved symptoms including 8 
with complete symptom resolution. Spontaneous clini-
cal resolution without antisecretory, anti-inflammatory 
or gastroprotective agents was noted in 5 patients 
(4 received only supplemental iron). Follow up endo-
histopathologic data (17 patients) included persistent 
collagen band and stable Mononuclear cell infiltrate 
in 12 patients with histopathologic improvement in 5 
patients. Neither collagen band thickness nor mono-
nuclear cell infiltrate correlated with clinical course. 
Intestinal metaplasia and endocrine cell hyperplasia 
were reported (1) raising the concern of long term 
malignant transformation. In summary, CG in children 
is a chronic disease, typically with a variable clinical re-
sponse and an indolent course that is distinct from the 
adult phenotype. Long term therapy usually inclused 
iron supplementation but cannot be standardized, giv-
en the chronicity of the disease, variability of response 
and potential for adverse events.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Collagenous gastritis (CG) is a rare idiopahic disorder 
characterized by the distinctive endoscopic-histopath-
ologic finding of  a thickened (> 10 μm) gastric sub-
epithelial collagen layer in association with inflammatory 
cell infiltrate in the lamina propria[1]. Collagenous gastritis 
was first described in a 15 years old by Colletti et al[2] 
subsequent reports helped define the two distinct phe-
notypes of  the disease in children and adult patients[1,3]. 
The classic pattern in children centers around upper 
gastrointestinal symptoms including abdominal pain and 
severe anemia[1,4-6]. In contrast to the adult phenotype, in-
flammatory changes and collagenous band deposition is 
usually limited to stomach and CG has a variable clinical 
and histopathological response to therapy[6,7]. Adult type 
CG is associated with several autoimmune processes and 
celiac disease[8] which is unusual in the childhood form. 
Concomitant collagenous colitis may be present and gas-
trointestinal symptoms include abdominal pain, malab-
sorptive symptoms and, protein loosing enteropathy[3,9]. 
Adult CG is characterized by the simultaneous occur-
rence of  collageneous colitis and duodenitis, and absence 
of  nodularity in the mucosa of  the colon and duodenum. 
The histological appearance of  adult onset CG is also 
characterized by extensive inflammation of  the entire 
gastrointestinal tract.
The pathophysiology of  collagenous gastritis is poor-
ly understood; one hypothesis includes a primary vascular 
abnormality with increased vascular permeability resulting 
in deposition of  extruded protein and collagen deposi-
tion. Alternatively a primary inflammatory process results 
in a secondary fibrotic scarring process in susceptible in-
dividuals. This is supported by the earlier observation of  
intraepithelial lymphocytic infiltrate and over expression 
of  human leukocyte antigen DR and CD25[2] suggesting 
an immune mediated inflammatory process.
Effective treatment of  CG in either age group remains 
elusive and poorly defined; treatment strategies have re-
volved around the etiopathologic observations suggesting 
an inflammatory process and the association with celiac 
disease. Both anti-inflammatory and anti-secretory mea-
sures as well as gluten free diet have been tried but there 
has been, to date, no comprehensive review of  treatment 
strategies and outcomes in this population. 
The purpose of  this study is to synthesize the pub-
lished experience for the clinical course and outcome 
following different treatment modalities in children with 
CG including two additional cases with one patient re-
sponsive to a combination of  oral budesonide in fish oil. 
CASE REPORT
We performed a comprehensive chart review of  the two 
cases of  pediatric Collagenous Gastritis presenting to 
our institution from 2009 to 2012, and accrued through 
query of  our institutional dedicated pediatric endoscopic 
database. Relevant historic, clinical, endoscopic-histologic 
findings and treatment modalities were summarized and 
pooled with the cases reported in the literature. 
Pooled literature analysis
We performed a literature search of  Pubmed and Ovid 
for terms: collagenous gastritis, lymphocytic gastritis and 
Collagenous colitis. Accrued publications were filtered 
for inclusion of  pediatric subjects. Related articles for rel-
evant publications were also reviewed. Articles including 
pediatric subjects were accrued. We identified sixty peer 
reviewed publications from Pubmed and an additional 30 
publications from Ovid. We excluded duplicate patient 
reports when identifiable and series where individual 
therapy and outcome pairs could not be determined. 
We abstracted relevant demographic, clinical, endo-
scopic-histopathologic findings at presentation and upon 
follow up whenever available and all therapeutic interven-
tions whenever reported. Reports defining therapeutic 
modalities and clinical or endoscopic-histopathologic 
outcome were included with our two cases above. 
Case 1
An 11 year old boy presented with profound, symptom-
atic iron deficiency anemia (hemoglobin 4.7 g/dL, mean 
corpuscular volume 52, serum iron 10 mg/dL, serum 
ferritin < 1.5 ng/dL), thrombocytosis (platelets were 
540 000/μL). Celiac serology was negative. Upper en-
doscopy and colonoscopy with biopsy showed marked 
inflammatory changes and nodularity in the gastric body 
mucosa but otherwise normal findings. The correspond-
ing gastric biopsies showed a mixed mucosal lymphocytic 
- neutrophilic infiltration and a prominent subepithelial 
collagen band (> 10 μm) that stained positive with Mas-
son Trichrome. Wireless capsule endoscopy was also 
negative. The patient was treated with oral iron supple-
ments, then standard dose omeprazole with continued 
periodic treatment with oral iron. Upon repeat esophago- 
gastroduodenoscopy at 16 years of  age biopsies showed 
marked interval improvement in gastritis, the develop-
ment of  multiple gastric (fundic gland) polyps and reso-
lution of  the collagenous band. He is asymptomatic and 
has been weaned off  omeprazole and is being monitored 
for iron deficiency.
Case 2 
A 7 years old girl presented with chronic, mild, diffuse 
abdominal pain and pallor. Laboratory investigations 
confirmed iron deficiency anemia (hemoglobin 4.6 g/dL, 
mean cell volume 59.7, serum ferritin < 1.5 ng/dL) with 
platelets count of  435 000/μL) normal inflammatory 
indices (erythrocyte sedimentation rate and C-reactive 
protein), and negative celiac serology. Upon upper en-
doscopy and colonoscopy with biopsy moderate to 
severe hemorrhagic gastropathy was noted and the cor-
responding biopsies were reported showing a thick Mas-
son Trichrome staining subepithelial hyaline band partly 
enveloping some of  the superficial glands and moderate 
superficial chronic inflammatory infiltrate (Figure 1). The 
rest of  the upper intestinal biopsies as well biopsies and 
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endoscopic findings on complete simultaneous colonos-
copy were normal. 
The patient received standard dose esomeprazole ap-
proximately 1 mg/kg per day and oral iron supplementa-
tion (sodium feredetate) for 6 mo but upon follow up 
was reporting episodic, postprandial abdominal pain with 
corresponding epigastric tenderness on exam. Repeat 
endoscopy showed unchanged gross and histopathologic 
findings. 
The treatment was escalated in view of  refractory 
disease to include budesonide capsules (6 mg) crushed 
and suspended in 5 mL of  fish oil given orally, daily and 
continuing esomeprazole and iron supplemention. Upon 
follow up, in 6 mo she was noted to have improved 
symptoms, mild constipation and was weaned off  supple-
mental iron. Repeat endoscopy showed grossly improved 
gastritis (minimal diffuse antral nodularity), interval de-
creased inflammatory infiltrate but persistent collagen 
band on most biopsies. The patient was continued on the 
same medical treatment regimen and on follow up after a 
further 6 mo was noted to be asymptomatic, with stable 
hematologic indices.
Our search identified 16 publications and 22 pediat-
ric cases with CG; their clinical presentation showed that 
anemia was predominantly observed in 17 cases (71%), 
Abdominal pain in 10 (41%), vomiting in 4 (17%), diar-
rhea in 4 (17%) and other presentations in 4 (17%) such 
as failure to thrive and hemoccult blood, hememesis and 
chest pain. their demographic data, therapeutic modali-
ties duration of  follow up and outcomes were pooled 
with our two cases and summarized in Table 1[1,2,4,6,9-20]. 
The majority of  patients (17) were female, the mean age 
at presentation was 11.7 years (SD 4.5 years) and similar 
for both genders. 
Gross endoscopic findings were abnormal in all re-
ported cases, several showed gastric mucosal nodularity 
(11/24). Other reported finding were erythema, erosions, 
ulceration and hemorrhages in the gastric body, fundus 
and to a lesser extent in antrum.
Simultaneous colonoscopic findings were reported in 
12 patients including 8 patients with gross and histologi-
cal normal findings; in 3 patients there was collagenous 
colitis. In addition, an infantile case showed diffuse 
atrophic mucosa and increased subcutaneous collagen 
throughout gastrointestinal (GI) tract sections[10,11].
When reported (18 patients), the duration of  follow 
up ranged (mean) between 0.2-14 (4) years. Duration of  
follow up did not significantly correlate with a consistent 
change in either outcome measure or disease phenotype. 
This is reflected by the reports by Winslow et al[13] and 
Kamimura et al[15], wherein follow up of  12 and 14 years 
respectively, and therefore into adulthood did not report 
features of  adult onset type CG.
Despite most subjects presenting with anemia, with 
one patient requiring blood transfusion, oral iron therapy 
was only documented in 12 patients. Other treatment 
modalities were antisecretory measures in 13 patients; 
Proton pump inhibitors (12), or histamine-2 blockers (3). 
This includes 3 patients who received triple therapy for 
Helicobacter pylori (H. pylori) gastropathy in relation to the 
findings of  CG. Sucralfate was used either alone or com-
bined with other therapy in 5 patients.
Oral steroids were trialed in 9 patients either as sys-
temic steroids (6) or oral budesonide (3) or were not 
specified (1). Steroids were used after other therapeutic 
modalities were ineffective. There were no cases reported 
in which steroids were able to eradicate the symptoms 
alone; in 6 cases intermittent response was noted; this in-
cluded improved hematological indices or normalization 
of  growth while recurrence of  symptoms occurred in 3 
cases after discontinuation of  therapy[1,10,17]. The use of  
topical steroids produced variable success in 3 cases[10,12] 
and case 2. Our case used budosonide in fish oil and 
showed clinical and hematological improvement that led 
to eventual weaning of  steroids.
In 6 individuals with CG treated with steroids and 
who underwent repeat endoscopy, histopathology was 
reported showing unchanged mononuclear (MN) cell 
infiltrate and collagen band in 3 patients increase in MN 
cells infiltrate in 2 patients and resolution of  MN cells 
with decreased thickness of  collagen in one case.
Additional measures included isolated patients treat-
ed with misoprostol, furazolidone, metronidazole and 
bismuth subsalicylate, hypoallergenic diet, gluten free 
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Figure 1  Gastric body surface epithelium showing marked thickening of subepithelial collagen in hematoxylin and eosin stain ×200 (arrow in A) or in mas-
son trichrome ×200 stain (arrow in B) with many intraepithelial lymphocytes.
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  Study Age/gender Treatment modalities F/U Histologic outcome Clinical outcome  
  Colletti et al[2] 15/F Ranitidine sucralfate and 
furazolidane
N/R No pathological improvement No clinical  improvement
  Côté et al[1]   9/F Oral iron, sucralfate, omeprazole 
prednisolone 
  2.5 Unchanged subepithelial collagen bands
Unchanged MN infiltrate
Unchanged chronic active gastritis
Intermittent epigastric pain
  Meunier et al[4]   11/M Oral iron   6.25 Chronic atrophic gastritis
Unchanged subepithelial collagen bands
Increasing severity MN infiltrate
N/R
12/F Oral iron   0.6 Unchanged histologic findings Asymptomtic
  Winslow et al[13] 14/F Sucralfate, ranitidine
Misoprostol, furazolidone
Clarithromycin
Metronidazole 
Omeprazole, prednisone
12 Progressive chronic active gastritis
Increasing severity MN infiltrate
Development of intestinal metaplasia
Linear endocrine cell hyperplasia
Stable subepithelial collagen bands
Intermittent abdominal 
pain
  Mahadevan et al[19] 15/F Blood transfusion   0.5 Unchanged collagen band N/R
  Kori et al[6] 12/F Oral iron
Omeprazole 
Clarithromycin-based triple therapy
  1 Severe erosive gastritis histologically and 
macroscopically
Intermittent nausea and 
vomiting
Normalized weight gain
12/F Oral, intravenous iron
Omeprazole 
Clarithromycin-based triple therapy, 
predinsone
  6 Unchanged subepithelial collagen bands
Stable MN infiltrate
Marked clinical 
improvement, normalized 
weight gain, anemia 
Resolved, intermittent 
epigastric pain
12/F Omeprazole   0.2 N/R Improved abdominal pain 
and heartburn
  Kamimura et al[15]   17/M No therapy 14 Increased collagen band thickness, 
moderate MN cell infiltrate
Asymptomatic
  Dray et al[14] 15/F Oral iron, triple therapy
Prolong PPI, predinsone
  0.83 N/R Clinical remission
  Ravikumara et al[20]   9/F Oral iron   4.1 Unchanged subepithelial collagen bands
Stable MN infiltrate
Decreased chronic gastritis
Asymptomatic
  Leiby et al[17] 0.16/M Steroids, PPI mesalamine
Bismuth subsalicylate
  6 N/R CG clinical improvement 
relapse after finishing 
steroids
  Brain et al[9] 16/F Ranitidine
Omeprazole
Oral iron, exclusion diet
N/R Unchanged histologic findings Asymptomatic
  Billiémaz et al[10] 0.75/M Prednisolone
Budesonide
Parenteral nutrition
Gluten free diet
14 Showed a diffuse atrophic mucosa and an 
increase in the subcutaneous collagen in 
the gastrointestinal tract
Complete clinical 
improvement with TPN
  Suskind et al[11]   9/F Oral iron   0.33 N/R Asymptomatic
  15/M Prednisone
Lansoprazole
Mesalamine 
  1 N/R Asymptomatic
  Leung et al[12] 15/F Budesonide   3.4  Moderate gastric collagen deposition that 
decreased in thickness no IEL 
Symptomatic improvement 
after therapy
14/F Pantoprazole
Sucralfate
N/R N/R No improvement
  19/M Sucralfate   0.25 Moderate gastric collagen deposition in 
body/fundus, no IEL
Symptomatic improvement 
  Wilson et al[16] 12/F Oral iron N/R N/R Aymptomatic
Normalized weight gain
  Camarero Salces et al[18]   9/F Meslalazine N/R Unchanged Unchanged
  This series
 
  11/M Oral iron
Omeprazole 
  5 Decreased/resolved collagen bands
Decreased chronic gastritis
Decreased MN infiltrate
(fundic gland polyps)
Improved abdominal pain  
  7/F Oral iron
Esomeprazole
Budesonide/fish oil
  1.5 Unchanged subepithelial collagen band Improved abdominal pain
Table 1  Demographic outline, treatment modalities, clinical course and outcome pooled cases of collagenous gastritis in children
F/U: Duration of follow up (yr); IEL: Intraepithelial lymphocytosis; MN: Mononuclear; N/R: Not reported; TPN: Total parentral nutrition; F: Female; M: 
Male; CG: Collagenous gastritis; PPI: Proton-pump inhibitor.
Hijaz NM et al . Collagenous gastritis management and outcome
1482 March 7, 2013|Volume 19|Issue 9|WJG|www.wjgnet.com
diet and parenteral nutrition. Mesalamine was prescribed 
in 3 cases that were reported with concomitant collag-
enous colitis.
The clinical outcome was reported in 22 patients, 
repeat endoscopy and therefore histologic follow up 
was reported only in 17 patients. Three out of  22 pa-
tients showed no clinical improvement despite therapy; 
conversely, 19 out of  24 were reported with improved 
symptoms including 8 patients with complete symptom 
resolution. Spontaneous clinical resolution without anti-
secretory, anti-inflammatory or gastroprotective agents 
was noted in 5 patients (4 received only supplemental 
oral iron).
Complete resolution of  symptoms was also reported 
after the use of  oral prednisone in a patient with con-
comitant CC whereas another three patients with con-
comitant CC treated with mesalamine were reported with 
variable response.
In the patients with repeat endoscopy-histopathology 
reported; persistent histopathologic abnormalities were 
reported in 12 cases including persistent collagen band 
and stable mononuclear cell infiltrate. Histopathologic 
improvement was shown in 5 cases, 3 of  them with 
decreased mononuclear cell infiltrate and decreased/re-
solved collagen bands in 2 patients on repeated endosco-
py. In contrast, mononuclear cell infiltrate was increased 
in 2 patients[3,13]. Neither MN cell infiltration nor the col-
lagen band changes correlated with the clinical course. 
Intestinal metaplasia and endocrine cell hyperplasia were 
reported in one case raising the concern of  long term 
malignant transformation[13].
DISCUSSION
Collagenous gastritis is a rare diagnosis in children; its 
pathophysiology is unknown and is complicated by over-
lap with lymphocytic gastritis and celiac disease[8,12]. Pe-
diatric CG is more common in girls and tends to present 
with severe anemia. In some cases pediatric CG coexists 
with collagenous sprue and collagenous colitis. The adult 
phenotype of  collagenous gastritis is, in turn, associated 
with autoimmune disorders. The natural history, treat-
ment modalities and long term outcome of  pediatric CG 
are unknown. Herein, in addition to reporting two new 
cases of  CG and a novel approach to treatment, we have 
reported on the most comprehensive review to date on 
the treatment modalities, response and outcome in chil-
dren with CG described in the peer-reviewed literature.
The demographic outline and clinical presentation of  
our filtered dataset of  treated children with CG and with 
described clinical and, or endoscopic-histopathologic 
outcomes reported appears representative of  the whole 
population of  pediatric cases reported in the literature. 
Our subset of  cases includes a predominance of  females, 
the mean age at diagnosis is 11.7 years and the duration 
of  reported follow up (4 years) attests to the chronicity 
of  the disease.
The presenting symptoms in our study; abdominal 
pain and iron deficiency anemia are identical to those 
reported elsewhere[9]. Although the pathophysiology of  
the iron deficiency remains unclear, most reports include 
the use of  enteral iron supplementation and we have not 
come across any reference to parenteral iron supplemen-
tation alone, suggesting that blood loss rather than mal-
absorption, is thought to be the cause of  iron deficiency. 
Half  the patients included in this series had under-
gone colonoscopy; four (16%) had collagenous colitis 
and three of  them were treated with anti-inflammatory 
measures including mesalamine[11,17,18]. It was unclear 
whether lower gastrointestinal symptoms were present in 
the patients undergoing colonoscopy; it is likely that, as in 
our patients, this was mandated by suspicion of  GI hem-
orrhage at the time of  presentation. The collagen deposi-
tion of  the entire gastrointestinal tract described in these 
cases was similar to those described in adult phenotype 
in their presentation. Although the reported subepithelial 
deposit in collagenous colitis tends to spread diffusely 
and continuously, collagen deposition and inflammatory 
infiltrate in collagenous gastritis tend to vary and are of-
ten irregular. The theory behind involvement of  colon in 
some of  these patients is that collagen bands arise from 
panenteric insult through the same pathological process 
in susceptible individuals, generally more severe in the 
colon in adulthood compared to children[9]. Anti-inflam-
matory drugs including corticosteroids have variable ef-
fect on collagenous colitis although relapses can occur, 
and diarrhea may resolve with or without treatment.
In our pooled analysis, coexistent collagenous colitis 
did not correlate with a worse prognosis. It is reasonable 
however to recommend colonoscopy in all patients with 
CG at the time of  initial diagnosis in view of  a potential 
response to therapy if  coexistent CC is diagnosed.
A proven therapeutic paradigm does not exist for CG 
and our review failed to define a consistent response to 
the therapeutic strategies that were reported in the litera-
ture. It appears that the consensus approach to the treat-
ment of  isolated CG includes oral supplementation to 
address iron deficiency as discussed above; anti-secretory 
strategies, especially proton-pump inhibitors, and anti-
inflammatory measures including systemic and, as in our 
case topically active steroids. In 3 of  the patients, con-
comitant H. pylori infections were noted and warranted 
triple therapy[6,14]. Measures to detect H. pylori on endos-
copy are therefore indicated when CG is diagnosed or 
suspected. This also raises interesting speculation of  the 
possible association of  H. pylori in the causation of  CG. 
A therapeutic strategy that includes long term anti-
secretory and anti-inflammatory measures has its limi-
tations, central to which, given the chronicity of  the 
disease, is adverse events from long-term treatment. This 
is especially true given that our analysis is the first to sug-
gest that pediatric CG is, in the most part an indolent, 
benign process. Adverse effects include systemic steroid 
side effects are exhaustively described elsewhere[21]. There 
are other potential adverse events, for example, the as-
sociation of  proton-pump inhibitor (PPI) use with neu-
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roendocrine tumors as suggested by Winslow et al[13] in 
one patient in our pooled reports. PPI are also reported 
to interfere with iron absorption[22]. It therefore follows 
that, in addition to a clear explanation of  our limited un-
derstanding of  the efficacy of  our treatment modalities, 
aside from oral iron supplementation, parents should also 
be offered treatments with the least adverse effects and 
for the shortest possible duration. Histamine-2-receptor 
Antagonists may be as suitable as PPI but entail less 
concern with long term use. Steroids may be considered 
a bridging therapy to achieve clinical and hematological 
response although there is a significant risk of  recur-
rence of  symptoms with discontinuation of  therapy. 
Budesonide may be as efficacious as, and entail less po-
tential for toxicity as systemic steroids.
There seems to be very limited evidence of  restric-
tion diet or gluten free diet improving CG. One patient 
was reported to respond to total parenteral nutrition but 
this seems an isolated case[10]. Several other treatment 
modalities (e.g., furazolidone) were also reported but 
with limited success. 
This report highlights the disconnect between the 
endoscopic-histopathologic abnormalities that, in the 
large part, persisted in those patients with follow up 
endoscopy and the clinical outcome that was typically 
benign. This is especially true of  the reported thickness 
of  the pathognomonic supepithelial collagen band that 
remained unchanged in most of  the patients. This obser-
vation contrasts with the conclusions drawn by Leung et 
al[12] who suggested that collagen thickness may correlate 
with severity of  disease. In addition, mononuclear cell in-
filtrate did not correlate with collagen band thickness or 
clinical outcome. 
In two reported cases, long term follow up over 12 
years and into adulthood did not; however show a rever-
sion to the adult-phenotype of  the disease. This includes 
a 35-year-old woman presenting with a nodular pattern 
on Barium X-ray screening study 14 years after her initial 
presentation[15]. In this patient the endoscopic and histo-
logical findings of  this disease were shown to progress 
gradually in absence of  therapy. Endoscopically, the 
nodular appearance became more conspicuous, in addi-
tion to a thicker collagen band evident on biopsy in the 
context, however, of  resolved clinical symptoms. In con-
trast, Winslow et al[13] reported on collagenous gastritis in 
a single patient who received multiple therapies including 
anti-inflammatory treatment during a 12-year period. The 
patient’s biopsy specimens showed a significant corpus 
endocrine cell hyperplasia, leading to speculation on an 
increased risk of  endocrine neoplasia with gradual pro-
gression in disease severity, and unchanged collagen band 
over the 12-year period. In both cases no colonic involve-
ment as described in adult phenotype reported after this 
long period. These reports suggest that the pediatric and 
adult disease phenotypes are different and that the pedi-
atric form does not evolve in the adult form. 
This study has several limitations; it is an attempt at 
a review of  case reports and case series that were not, in 
the large part focused on therapy, response or long term 
outcome. There is potentially significant heterogeneity in 
the accuracy of  reporting follow up duration, therapeutic 
modalities, histopathological and clinical response. Our 
sample size is a further significant limitation that impacts 
on the conclusions that can be drawn. Further studies 
with a more consistent method of  qualifying endoscopic-
histologic abnormalities are needed. 
In conclusion, collagenous gastritis in children tends 
to be an isolated process that follows a generally benign 
course with limited long-term morbidity and no increased 
mortality reported to date. Initial investigation in chil-
dren with CG needs to include investigation for H. pylori 
and colonoscopy to rule out collagenous colitis. Routine 
extensive investigation for autoimmune disorders ap-
pears unjustified. Response to medication is variable and 
needs to be individualized with the proviso that anecdotal 
evidence synthesized in this paper supports the use of  
oral iron supplementation and the judicious use of  anti-
secretory and anti-inflammatory agents for the shortest 
time feasible. 
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